Document is current
Any future updates will be listed below
-
Authors
French, Leon https://orcid.org/0000-0002-9409-4583
Suresh, Hamsini https://orcid.org/0000-0001-9133-1929
Gillis, Jesse https://orcid.org/0000-0002-0936-9774
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U24MH130968)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH133181)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113005)
- License Information
-
More Information
Article History
Received: 10 April 2025
Accepted: 28 May 2026
First Online: 23 June 2026
Ethics
Competing interests: L.F. owns shares in Quince Therapeutics and has received consulting fees from PeopleBio Co., GC Therapeutics Inc., Cortexyme Inc., and Keystone Bio. The remaining authors declare no competing interests.
